Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Primaquine for Gametocytocidal Activity in Malaria
NCT01743820Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of primaquine in Plasmodium falciparum malaria, sponsored by University of California, San Francisco. Started Sep 2013; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01743820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743820.